Conference

WA Addictions Symposium

Date

28 October 2023

Location

Entrance 1, Hackett Drive
Crawley, WA 6009

Delivery

In-person
Addiction Conference talk WA

Trips, Tokes & Traps
Changing evidence and changing laws
Psychedelics, medicinal cannabis, prescribed medication and driving assessments, vaping

Presented by the RANZCP WA Faculty of Addiction Psychiatry, this event gives you the opportunity to learn from local and interstate experts. 

Program

Detailed program to be released soon.

Speakers

Graphic-ProfileArc

Prof Nicholas Lintzeris

Professor Nicholas Lintzeris (MBBS, PhD, FAChAM) is a clinician who has worked for over 30 years in the area of cannabis and other addictions and is a national reference regarding cannabinoid behaviour and response in humans. He also has a wealth of expertise in pharmacovigilance of medicines with abuse potential, such as opioid and benzodiazepine pharmacovigilance.

Although ACRE is focused on developing an efficacy and safety evidence base for the medicinal aspects of cannabinoids, it is recognized that either actual or perceived abuse potential of cannabinoids by the community and health practitioners is a major hurdle to research into safe implementation of cannabinoid therapeutic goods in practice. Nicholas also has expertise in clinical trials regarding medicinal cannabinoids, including outcome, safety and cost effectiveness assessments

Professor Nicholas Lintzeris (MBBS, PhD, FAChAM) is a clinician who has worked for over 30 years in the area of cannabis and other addictions and is a national reference regarding cannabinoid behaviour and response in humans. He also has a wealth of expertise in pharmacovigilance of medicines with abuse potential, such as opioid and benzodiazepine pharmacovigilance.

Although ACRE is focused on developing an efficacy and safety evidence base for the medicinal aspects of cannabinoids, it is recognized that either actual or perceived abuse potential of cannabinoids by the community and health practitioners is a major hurdle to research into safe implementation of cannabinoid therapeutic goods in practice. Nicholas also has expertise in clinical trials regarding medicinal cannabinoids, including outcome, safety and cost effectiveness assessments

Graphic-ProfileArc

Prof Edward Ogden

Professor Ogden obtained his degrees from the University of Melbourne. He is a Fellow of the Royal Australian College of General Practitioners, a Fellow of the Chapter of Addiction Medicine of the Royal Australian College of Physicians and a Fellow of the Faculty of Clinical Forensic Medicine of the Royal College of Pathologists of Australasia. He was awarded the Public Service Medal for services to Forensic Medicine on Australia Day 2005.

His research interests focus on the role of alcohol and drugs in traffic safety and development of treatments for alcohol and drug abuse based on applying current understanding of the neurobiology of addiction into meaningful clinical treatments.

Professor Ogden obtained his degrees from the University of Melbourne. He is a Fellow of the Royal Australian College of General Practitioners, a Fellow of the Chapter of Addiction Medicine of the Royal Australian College of Physicians and a Fellow of the Faculty of Clinical Forensic Medicine of the Royal College of Pathologists of Australasia. He was awarded the Public Service Medal for services to Forensic Medicine on Australia Day 2005.

His research interests focus on the role of alcohol and drugs in traffic safety and development of treatments for alcohol and drug abuse based on applying current understanding of the neurobiology of addiction into meaningful clinical treatments.

Graphic-ProfileArc

Associate Prof Matthew Coleman

Associate Professor Mathew Coleman is a consultant psychiatrist with the WA Country Health Service, Clinical Director for the Midwest Mental Health service and Clinical Academic with the Rural Clinical School of WA. He is a qualified child and adolescent, and addiction psychiatrist and has experience and qualifications in health service management. He was the co-author of the RANZCP learning modules on smoking cessation and nicotine vaping products.

Associate Professor Mathew Coleman is a consultant psychiatrist with the WA Country Health Service, Clinical Director for the Midwest Mental Health service and Clinical Academic with the Rural Clinical School of WA. He is a qualified child and adolescent, and addiction psychiatrist and has experience and qualifications in health service management. He was the co-author of the RANZCP learning modules on smoking cessation and nicotine vaping products.

Pricing

In person Fellow / Affiliate ticket price $143
In person Trainee ticket price $121
Online Fellow/ Affiliate ticket price $128
Online Trainee ticket price $106


Please note that the sessions will not be recorded, and you will only be able to watch the presenters live as they present.

CPD certificates of attendance available upon request to angie.padoan@ranzcp.org

Directions

Parking is free on a Saturday at The UWA Club.

A meeting link for online attendances will be sent out closer to the date of the meeting.

Contact

For more information please contact the RANZCP WA Branch Coordinator on angie.padoan@ranzcp.org.

Terms and conditions

Cancellation policy

No refunds will be issued from Monday 23 October.

COVID 19 compliance

The RANZCP is committed to the health and safety of all members, meeting participants and maintaining a safe system of work for staff. Whilst not mandatory, high-quality face masks and pre-arrival testing (Rapid Antigen Tests) are encouraged to ensure the health and wellbeing of colleagues and staff is maintained.